Form 4: Zymeworks CEO Kenneth Galbraith Acquires Stock Options and Restricted Stock Units

Zymeworks CEO Kenneth Galbraith was granted 288,000 stock options and 192,000 restricted stock units on January 10, 2025.

Summary

• Kenneth Galbraith, the CEO of Zymeworks Inc., has acquired 288,000 stock options and 192,000 restricted stock units.
• The stock options have an exercise price of $13.22 and expire on January 9, 2035.
• The stock options vest over time, with 25% vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments.
• The restricted stock units (RSUs) vest in three equal annual installments starting on the first anniversary of the grant date.
• Each RSU represents the right to receive one share of Zymeworks common stock upon vesting.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with shareholder interests. There are no negative implications.

Positives

• The grant of stock options and RSUs to the CEO aligns his interests with those of the shareholders.
• The vesting schedule of the stock options and RSUs encourages long-term performance and retention of the CEO.

Industry Context

The granting of stock options and restricted stock units is a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice for executive compensation in the biotech industry, often used to align management interests with shareholder value creation.
• The vesting schedules described are typical, with a mix of time-based vesting to encourage long-term commitment.
• Comparable companies in the biotech sector often use similar equity-based compensation packages to attract and retain top talent.

Stakeholder Impact

• The grant of stock options and RSUs could positively impact shareholder value if the CEO's performance leads to an increase in the company's stock price.
• The vesting schedule encourages the CEO to remain with the company, which can provide stability for employees and other stakeholders.

Key Dates

Keywords

stock options, restricted stock units, RSU, executive compensation, insider trading, Zymeworks, ZYME, Kenneth Galbraith